Outcome
    Preliminary

    Quercetin for Inflammaging Reduction

    Quercetin has senolytic interest but human anti-inflammatory data in ageing are preliminary.

    Overview

    Quercetin has senolytic interest but human anti-inflammatory data in ageing are preliminary.

    Verdict

    Mixed evidence

    How It Works

    Quercetin inhibits NF-kB and, combined with dasatinib in animal work, clears senescent cells that secrete inflammatory mediators.

    Dosing & Protocol

    Typical dose

    Recommended dose
    500-1000 mg daily of a bioavailable form
    Expected timeframe
    8-12 weeks

    Protocol

    form
    Bioavailability-enhanced quercetin. Note that senolytic research protocols used a different approach entirely - quercetin 1,000 mg with dasatinib 100 mg, a prescription chemotherapy drug, for 3 consecutive days repeated intermittently
    duration
    8-12 weeks for inflammatory markers
    co factor
    Take with food containing fat. Evidence is mixed. Quercetin reduces inflammatory markers in some human trials - meta-analyses show modest reductions in CRP, particularly at doses of 500 mg/day or more, in trials of 8 weeks or longer, and in people with elevated baseline inflammation - while other trials show nothing. The senolytic angle is separate and much less established: small pilot studies in idiopathic pulmonary fibrosis and diabetic kidney disease used dasatinib plus quercetin and reported reduced senescent cell burden, but these were tiny, uncontrolled and used a prescription drug alongside.
    titration
    Up to 500 mg twice daily for continuous use; 1,000 mg/day for up to 12 weeks is the studied ceiling
    starting dose
    500 mg once daily with a fat-containing meal for continuous use

    Evidence

    What the studies say

    Human trials are small and short, with inconsistent effects on CRP. The senolytic combination work remains early-phase and is not a basis for self-treatment.

    No studies are yet linked to both Quercetin and Inflammaging Reduction.

    Safety

    Caveats

    Poor absorption unbuffered; interacts with several drug-metabolising enzymes.

    Less likely to help if

    People with normal inflammatory markers, and anyone expecting senolytic effects from quercetin alone.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.